MedPath

Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction

Not Applicable
Completed
Conditions
Intraoperative Hypotension
Interventions
Procedure: Continuous norepinephrine administration
Registration Number
NCT05940649
Lead Sponsor
Kristen Thomsen
Brief Summary

Intraoperative hypotension is common in patients having non-cardiac surgery with general anesthesia and is associated with organ injury and death. The timely treatment of intraoperative hypotension is thus important to avoid postoperative complications. About one third of intraoperative hypotension occurs during anesthetic induction - i.e., between the start of anesthetic induction and surgical incision. Hypotension during anesthetic induction is associated with postoperative acute kidney injury.

Unmodifiable risk factors for hypotension during anesthetic induction include age, male sex, and a high American Society of Anesthesiologists physical status class. However, hypotension during anesthetic induction is mainly driven by modifiable factors - specifically, anesthetic drugs that cause vasodilation.

In most German hospitals, norepinephrine is the first-line vasopressor to treat hypotension during anesthetic induction. Norepinephrine is usually given as repeated manual boluses of 5, 10, or 20 μg. The continuous administration of norepinephrine via a perfusion pump is usually started only later. It remains unknown whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction.

We thus propose to investigate whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction in non-cardiac surgery patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
262
Inclusion Criteria
  • non-cardiac surgery
  • >45 years of age
  • American Society of Anesthesiologists physical status classification II, III, and IV.
Exclusion Criteria
  • Planned intraarterial blood pressure monitoring during anesthetic induction with an arterial catheter
  • Emergency surgery
  • Transplant surgery
  • History of organ transplant
  • Pregnancy
  • Heart rhythms other than sinus rhythm
  • Impossible Finger-cuff blood pressure monitoring
  • Rapid sequence induction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous norepinephrine administrationContinuous norepinephrine administration-
Primary Outcome Measures
NameTimeMethod
Hypotension during anesthetic inductionFirst 15 minutes of anesthetic induction

Area under a MAP of 65 mmHg \[mmHg x min\]

Secondary Outcome Measures
NameTimeMethod
Hypotension during anesthetic inductionFirst 15 minutes of anesthetic induction

Cumulative dose of norepinephrine indexed to body weight \[μg kg-1\]

Hypertension during anesthetic inductionFirst 15 minutes of anesthetic induction

Absolute \[n\] and relative \[%\] number of patients with any MAP measurement \>100, \>110, \>120 and \>140 mmHg

Trial Locations

Locations (1)

University Medical Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath